ANDREA SCHWAB: Open Payments
NPI 1205411881 · LOCKPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,522 in 82 payments from 23 companies in 2025. Trend: 2023 $521 · 2024 $1,077 · 2025 $1,522
Food & beverage: $1,522
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $220 |
| AstraZeneca Pharmaceuticals LP | 10 | $175 |
| GlaxoSmithKline, LLC. | 9 | $165 |
| Novo Nordisk Inc | 10 | $147 |
| Exact Sciences Corporation | 5 | $112 |
| Corcept Therapeutics | 6 | $112 |
| ABBVIE INC. | 3 | $75 |
| PFIZER INC. | 3 | $62 |
| Lilly USA, LLC | 3 | $56 |
| Dexcom, Inc. | 3 | $50 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, OTEZLA, Cologuard Collection Kit, Korlym, Ozempic, REPATHA, NURTEC ODT.
Industry payments across NY — which companies pay providers there.
